Many people assume cancer begins with pain. In many cases, it does not. Several cancers develop without clear or early symptoms and can remain unnoticed for a long time. There may be no discomfort, no visible sign, and no immediate change in day-to-day functioning. When pain does occur, the disease may already have progressed. This difference between common belief and medical reality often affects how quickly people go for a check-up and when a diagnosis is finally made.
Dr Sabine Kapasi, Global Health Strategist and UN Advisor, shares what you need to know:
Cancers That Commonly Stay Silent Early
Several common cancers are known to remain silent in their initial phases. Ovarian cancer often presents with non-specific complaints such as bloating or abdominal discomfort that are easily attributed to diet or lifestyle. Pancreatic cancer may not produce noticeable symptoms until it has spread. Liver cancer can progress without clear early signals while liver reserve gradually declines. Colon cancer may remain unnoticed until bleeding or obstruction occurs. Kidney tumors are frequently detected incidentally during scans conducted for unrelated reasons. These patterns are well documented in clinical settings.
Why Early-Stage Disease Often Does Not Hurt
The absence of pain in early disease is not unusual. Pain usually results when a tumor grows large enough to press on nerves, block an organ, or trigger inflammation. Smaller or early-stage tumors often do not produce such effects. As a result, waiting for discomfort before seeking medical evaluation can lead to delayed diagnosis. How long a cancer stays undetected differs from case to case. It varies by cancer type, biology, and individual risk factors. In some cases, this interval can extend over years.
Limits of Symptom-Based Detection
This has direct implications for public health planning. A system that depends mainly on symptom-based diagnosis will continue to detect many cancers late. Screening and risk-based surveillance are therefore central to better outcomes. Established screening tools, such as mammography for breast cancer, cervical screening, colonoscopy, and targeted lung scans for high-risk groups, are designed to find disease before symptoms begin. Where screening coverage is strong, earlier detection rates improve and treatment is often less extensive.